MoonLake Immunotherapeutics (MLTX)

NCM – Real Time Price. Currency in USD

17.23

+0.64 (3.83%)

Market open: Aug 12, 2026, 3:45 PM EDT

16.67

+0.08 (0.49%)

Previous after-hours: Aug 11, 2026, 7:54 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-3M

-1M

-13K

-12K

Gross Profit

-3M

-1M

-13K

-12K

Operating expenses (excl. COGS)

-242M

-142M

-54M

-65M

Operating Income

-245M

-143M

-54M

-65M

Non-operating income, total

15M

22M

10M

592K

Pretax income

-230M

-121M

-44M

-64M

Equity in earnings

Taxes

-611K

-282K

-94K

-36K

Non-controlling/minority interest

15M

After tax other income/expense

Net income before discontinued operations

-227M

-119M

-36M

-50M

Discontinued operations

Net income

-227M

-119M

-36M

-50M

Dilution adjustment

Preferred dividends

MoonLake Immunotherapeutics (MLTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

MoonLake Immunotherapeutics (MLTX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

MoonLake Immunotherapeutics (MLTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

MoonLake Immunotherapeutics (MLTX)

Income Statement (Annual)

Income Statement (Annual)